PCI Biotech Holding
Be the first to follow this company
PCI Biotech Holding is a biopharmaceutical group, where most of the operations are conducted within the subsidiary PCI Biotech. The Group currently conducts operations in the development of therapeutic products based on the proprietary PCI technology. The solutions are intended for use in the treatment of cancer patients. PCI Biotech was originally founded in 2000 as a subsidiary of Photocure and is headquartered in Oslo.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
Oslo Børs
PCIB
Daily low / high price
-
Market cap
-
Turnover
-
Volume
-
Financial calendar
Interim report
2024-08-28
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Fondsavanse AS | 10.5 % | 10.5 % |
MP Pensjon PK | 4.3 % | 4.3 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Disclosure of voting rights for Chair of the Board
PCI Biotech Holding ASA - Notice of Annual General Meeting 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools